|
FY2026
12 months to Apr 24, 2026
|
|
|---|---|
| Net sales | |
| Cost of products sold | |
| Gross profit | |
| Operating expenses: | |
| Research and development expense | |
| Selling, general, and administrative expense | |
| Certain litigation charges, net | |
| Other operating expense (income), net | |
| Operating loss | |
| Other non-operating expense (income), net | |
| Loss before income taxes | |
| Income tax provision | |
| Net loss | |
| Net income attributable to noncontrolling interests | |
| Net loss attributable to the Company | |
| Earnings (loss) per share: | |
| Earnings (loss) per share, basic (usd per share) | |
| Earnings (loss) per share, diluted (usd per share) | |
| Weighted-average shares outstanding | |
| Basic weighted average shares outstanding (shares) | |
| Diluted weighted average shares outstanding (shares) |
Loading...
